TP53 and neoplasm: This so called p53-dependent cyclotherapy using p53 activators stops proliferation of normal cells / healthy tissues via cell cycle arrest, while leaving the p53-deficient tumor susceptible to the conventional chemotherapy (DNA-damaging agents, microtubule poisons) [47-49].